A retrospective analysis of the natural history of primary IgA nephropathy worldwide
- PMID: 2200265
- DOI: 10.1016/0002-9343(90)90300-3
A retrospective analysis of the natural history of primary IgA nephropathy worldwide
Abstract
The worldwide medical literature was reviewed to determine whether the prevalence, clinical presentation, and immunohistologic findings of primary IgA nephropathy were related to geographic areas. A total of 68 reports containing detailed clinical histories and laboratory findings were analyzed. The selected articles were grouped according to their geographic origin: Asia, Australia, Europe, and North America (Canada and the United States). Analysis of the data showed that IgA nephropathy is more frequent in the Asian area than in Australia, Europe, and North America. The male/female ratio indicates that males are more likely to be affected by the disease, particularly in the second and third decade of life. The appearance of the disease is characterized by microscopic hematuria and mild proteinuria in Asians, whereas gross hematuria is more frequent in American and European patients. At the time of renal biopsy, fixed microscopic hematuria is detected in a high percentage of patients in Asia and Europe, whereas macroscopic hematuria is more frequent in American patients. Mild renal lesions occur more frequently in Asian patients, while severe renal lesions and a high frequency of immunoglobulin and complement deposits are present in American and European patients. Differences encountered in this retrospective analysis may be influenced by two important factors: (1) the absence of urinalysis screening programs in the schools of Europe and North America, and (2) the different approaches to renal biopsy in the eastern and western parts of the world. Due to the high rate of renal insufficiency and end-stage kidney disease in European and North American patients with IgA nephropathy, it is recommended that a program of urinalysis screening in schools and an appropriate renal biopsy policy be adopted in the western areas of the world.
Similar articles
-
[IgA nephropathy. A frequent disease in the Mediterranean area].Recenti Prog Med. 1991 Jun;82(6):338-43. Recenti Prog Med. 1991. PMID: 1924991 Review. Italian.
-
Epidemiology of IgA Nephropathy: A Global Perspective.Semin Nephrol. 2018 Sep;38(5):435-442. doi: 10.1016/j.semnephrol.2018.05.013. Semin Nephrol. 2018. PMID: 30177015
-
Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy.Am J Kidney Dis. 1991 Apr;17(4):472-9. doi: 10.1016/s0272-6386(12)80643-3. Am J Kidney Dis. 1991. PMID: 2008917
-
IgA nephropathy: clinical features and natural history--a pediatric perspective.Am J Kidney Dis. 1988 Nov;12(5):358-61. doi: 10.1016/s0272-6386(88)80024-6. Am J Kidney Dis. 1988. PMID: 3055957 Review.
-
Clinical, histopathological and immunofluorescent findings of IgA nephropathy.Iran J Immunol. 2011 Jun;8(2):104-10. Iran J Immunol. 2011. PMID: 21705838
Cited by
-
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.Pediatr Nephrol. 2015 Jul;30(7):1113-20. doi: 10.1007/s00467-014-3024-z. Epub 2014 Dec 31. Pediatr Nephrol. 2015. PMID: 25549975
-
A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy.Front Immunol. 2019 Mar 22;10:537. doi: 10.3389/fimmu.2019.00537. eCollection 2019. Front Immunol. 2019. PMID: 30967869 Free PMC article. Clinical Trial.
-
Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.Clin Exp Nephrol. 2012 Feb;16(1):122-9. doi: 10.1007/s10157-011-0530-1. Epub 2011 Sep 13. Clin Exp Nephrol. 2012. PMID: 21912900
-
T-cell epitopes recognized within the 65,000 MW hsp in patients with IgA nephropathy.Immunology. 1997 Jul;91(3):399-405. doi: 10.1046/j.1365-2567.1997.00279.x. Immunology. 1997. PMID: 9301529 Free PMC article.
-
ABO blood type is associated with renal outcomes in patients with IgA nephropathy.Oncotarget. 2017 Sep 7;8(43):73603-73612. doi: 10.18632/oncotarget.20701. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088730 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous